Related Experiment Video
Updated: Jul 2, 2025

07:51
The C-seal: A Biofragmentable Drain Protecting the Stapled Colorectal Anastomosis from Leakage
Published on: November 4, 2010
21.9K
Sprayable Hydrogel Sealant for Gastrointestinal Wound Shielding
Gonzalo Muñoz Taboada1,2, Daniel Dahis1, Pere Dosta3,4,5
1BioDevek, Boston, MA, 02134, USA.
Advanced Materials (Deerfield Beach, Fla.)
|February 29, 2024
Summary
A new sprayable hydrogel provides a sustained adhesive shield for gastrointestinal lesions, significantly reducing delayed complications like bleeding and perforation after procedures.
Area of Science:
- Biomaterials Science
- Gastroenterology
- Medical Devices
Background:
- Delayed adverse events, including bleeding and perforation, occur 5-7 days post-gastrointestinal procedures.
- Current hemostatic agents offer limited adhesion (less than 48 hours) to gastrointestinal mucosal tissues.
- Existing solutions are insufficient for managing intra- and post-procedural complications effectively.
Purpose of the Study:
- To develop and evaluate a novel sprayable adhesive hydrogel for gastrointestinal (GI) lesion management.
- To assess the hydrogel's ability to provide sustained adhesion and tissue protection.
- To confirm the safety and efficacy of the hydrogel in preventing delayed post-operative complications.
Main Methods:
- Development of a sprayable biomaterial precursor (polyethyleneimine-modified Pluronic micelles and oxidized dextran) that instantly gels upon contact.
- Application of the hydrogel using clinically available endoscopes for facile delivery to GI lesions.
- In vitro and in vivo testing in animal models (guinea pigs, rabbits, pigs) to evaluate safety, adhesion, and efficacy on colonic and stomach lesions.
Main Results:
- The sprayable hydrogel demonstrated instant gelation and formed a robust adhesive shield on GI tissues.
- In vivo studies confirmed the biomaterial's safety and efficacy in both colonic and acidic stomach lesion models.
- The hydrogel provided prolonged tissue protection, lasting 3-7 days, and facilitated wound healing.
Conclusions:
- The developed hydrogel offers a promising, readily adoptable solution for gastrointestinal wound management.
- This technology effectively minimizes the risk of delayed complications by providing sustained tissue protection.
- The sprayable adhesive hydrogel represents a significant advancement in endoscopic intervention and GI lesion care.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
485
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
485
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
435
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
435

